5 Buy-Rated Stocks with Latest Insider Purchases

4. Anixa Biosciences Inc (NASDAQ:ANIX)

Average Analyst Price Target: $12

Upside Potential: 278%

On April 9, 2024, Lewis H. Titterton Jr., a one of the directors at Anixa Biosciences Inc (NASDAQ:ANIX), piled into 15,009 shares at $3.28 per share. The total value of this transaction was $49,230 per share. Since the date of this transaction Anixa Biosciences Inc (NASDAQ:ANIX) stock has lost about 2.5% in value.